Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials

Authors

Anne C Goldberg, Washington University School of Medicine in St. Louis
Maciej Banach, Medical University of Łódź
Alberico L Catapano, IRCCS Multimedica
P Barton Duell, Oregon Health & Science University
Lawrence A Leiter, University of Toronto
Jeffrey C Hanselman, Esperion Therapeutics Inc.
Lei Lei, Esperion Therapeutics Inc.
G B John Mancini, University of British Columbia

Journal

Atherosclerosis

Publication Date

11-1-2023

Volume

384

First Page

117192

Document Type

Open Access Publication

DOI

10.1016/j.atherosclerosis.2023.117192

Rights and Permissions

Goldberg AC, Banach M, Catapano AL, Duell PB, Leiter LA, Hanselman JC, Lei L, Mancini GBJ. Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials. Atherosclerosis. 2023 Nov;384:117192. doi: 10.1016/j.atherosclerosis.2023.117192. © 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Recommended Citation

Goldberg, Anne C; Banach, Maciej; Catapano, Alberico L; Duell, P Barton; Leiter, Lawrence A; Hanselman, Jeffrey C; Lei, Lei; and Mancini, G B John, "Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials." Atherosclerosis. 384, 117192 (2023).
https://digitalcommons.wustl.edu/oa_4/3504

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.